Depression as a risk factor for adverse outcomes in coronary heart disease

BMC Medicine

Robert M Carney¹  Kenneth E Freedland¹ 

[1] Department of Psychiatry, Washington University School of Medicine, 4320 Forest Park Avenue, Suite 301, St Louis, Missouri 63108, USA

关键词: Psychotherapy;    Myocardial infarction;    Mortality;    Depressive disorder;    Depression;    Coronary disease;    Antidepressive agents;    Acute coronary syndrome;   

Others  :  857027
DOI  :  10.1186/1741-7015-11-131

 received in 2012-11-14, accepted in 2013-05-01,  发布年份 2013

【 摘 要 】

Background

Depression is firmly established as an independent predictor of mortality and cardiac morbidity in patients with coronary heart disease (CHD). However, it has been difficult to determine whether it is a causal risk factor, and whether treatment of depression can improve cardiac outcomes. In addition, research on biobehavioral mechanisms has not yet produced a definitive causal model of the relationship between depression and cardiac outcomes.

Discussion

Key challenges in this line of research concern the measurement of depression, the definition and relevance of certain subtypes of depression, the temporal relationship between depression and CHD, underlying biobehavioral mechanisms, and depression treatment efficacy.

Summary

This article examines some of the methodological challenges that will have to be overcome in order to determine whether depression should be regarded as a key target of secondary prevention in CHD.

【 授权许可】

   
2013 Freedland and Carney; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Charlson FJ, Stapelberg NJ, Baxter AJ, Whiteford HA: Should global burden of disease estimates include depression as a risk factor for coronary heart disease? BMC Med 2011, 9:47. BioMed Central Full Text
• [2]Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de JP: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011, 33:203-216.
• [3]Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004, 66:802-813.
• [4]Nicholson A, Kuper H, Hemingway H: Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774.
• [5]van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, van den Brink RH, van den Berg MP: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004, 66:814-822.
• [6]Kuper H, Nicholson A, Kivimaki M, Aitsi-Selmi A, Cavalleri G, Deanfield JE, Heuschmann P, Jouven X, Malyutina S, Mayosi BM, Sans S, Thomsen T, Witteman JC, Hingorani AD, Lawlor DA, Hemingway H: Evaluating the causal relevance of diverse risk markers: horizontal systematic review. BMJ 2009, 339:b4265.
• [7]Carney RM, Freedland KE, Miller GE, Jaffe AS: Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002, 53:897-902.
• [8]Skala JA, Freedland KE, Carney RM: Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry 2006, 51:738-745.
• [9]Carney RM, Freedland KE: Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009, 166:410-417.
• [10]Simon GE, Von KM: Medical co-morbidity and validity of DSM-IV depression criteria. Psychol Med 2006, 36:27-36.
• [11]Freedland KE, Lustman PJ, Carney RM, Hong BA: Underdiagnosis of depression in patients with coronary artery disease: the role of nonspecific symptoms. Int J Psychiatry Med 1992, 22:221-229.
• [12]Koenig HG, George LK, Peterson BL, Pieper CF: Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry 1997, 154:1376-1383.
• [13]Ward LC: Comparison of factor structure models for the Beck Depression Inventory–II. Psychol Assess 2006, 18:81-88.
• [14]Quilty LC, Zhang KA, Bagby RM: The latent symptom structure of the Beck Depression Inventory-II in outpatients with major depression. Psychol Assess 2010, 22:603-608.
• [15]American Psychiatric Association: American Psychiatric Association, Task Force on DSM-IV. 4th edition. Washington: DC: American Psychiatric Association; 2000. [Diagnostic and Statistical Manual of Mental Disorders] text revsion
• [16]O'Keeffe N, Ranjith G: Depression, demoralisation or adjustment disorder? Understanding emotional distress in the severely medically ill. Clin Med 2007, 7:478-481.
• [17]Lespérance F, Frasure-Smith N, Talajic M: Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996, 58:99-110.
• [18]Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, Davidson KW, Czajkowski SM, Jaffe AS: History of depression and survival after acute myocardial infarction. Psychosom Med 2009, 71:253-259.
• [19]Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, Czajkowski SM, Frank E, Frasure-Smith N, Freedland KE, Froelicher ES, Glassman AH, Katon WJ, Kaufmann PG, Kessler RC, Kraemer HC, Krishnan KR, Lespérance F, Rieckmann N, Sheps DS, Suls JM: National Heart, Lung, and Blood Institute Working Group: Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med 2006, 68:645-650.
• [20]Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study, Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282:1737-1744.
• [21]Kroenke K, Spitzer RL, Williams JB: The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003, 41:1284-1292.
• [22]Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH: The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009, 114:163-173.
• [23]Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
• [24]Beck AT, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
• [25]Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA: The Composite International Diagnostic Interview, an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988, 45:1069-1077.
• [26]Freedland KE, Skala JA, Carney RM, Raczynski JM, Taylor CB, Mendes de Leon CF, Ironson G, Youngblood ME, Krishnan KR, Veith RC: The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 2002, 64:897-905.
• [27]Dao TK, Chu D, Springer J, Gopaldas RR, Menefee DS, Anderson T, Hiatt E, Nguyen Q: Clinical depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress disorder as risk factors for in-hospital mortality after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg 2010, 140:606-610.
• [28]Scherrer JF, Virgo KS, Zeringue A, Bucholz KK, Jacob T, Johnson RG, True WR, Carney RM, Freedland KE, Xian H, Caplan L, McDonald J, Eisen SA: Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. Gen Hosp Psychiatry 2009, 31:353-359.
• [29]Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA: Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001, 88:337-341.
• [30]Grace SL, Abbey SE, Kapral MK, Fang J, Nolan RP, Stewart DE: Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005, 96:1179-1185.
• [31]Strik JJ, Honig A, Lousberg R, Denollet J: Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001, 42:423-428.
• [32]Thombs BD, Magyar-Russell G, Bass EB, Stewart KJ, Tsilidis KK, Bush DE, Fauerbach JA, McCann UD, Ziegelstein RC: Performance characteristics of depression screening instruments in survivors of acute myocardial infarction: review of the evidence. Psychosomatics 2007, 48:185-194.
• [33]Bunevicius A, Staniute M, Brozaitiene J, Bunevicius R: Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients. J Psychosom Res 2012, 72:22-25.
• [34]McManus D, Pipkin SS, Whooley MA: Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 2005, 96:1076-1081.
• [35]Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988, 50:627-633.
• [36]Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993, 270:1819-1825.
• [37]Kaufmann MW, Fitzgibbons JP, Sussman EJ, Reed JF 3rd, Einfalt JM, Rodgers JK, Fricchione GL: Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999, 138:549-554.
• [38]Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Jaffe AS: Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 2003, 92:1277-1281.
• [39]Frasure-Smith N, Lesperance F: Recent evidence linking coronary heart disease and depression. Can J Psychiatry 2006, 51:730-737.
• [40]Vieweg WV, Hasnain M, Lesnefsky EJ, Turf EE, Pandurangi AK: Assessing the presence and severity of depression in subjects with comorbid coronary heart disease. Am J Med 2010, 123:683-690.
• [41]Krueger RF, Bezdjian S: Enhancing research and treatment of mental disorders with dimensional concepts: toward DSM-V and ICD-11. World Psychiatry 2009, 8:3-6.
• [42]Carney RM, Freedland KE, Jaffe AS: Insomnia and depression prior to myocardial infarction. Psychosom Med 1990, 52:603-609.
• [43]Hoen PW, Whooley MA, Martens EJ, Na B, van Melle JP, de Jonge P: Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol 2010, 56:838-844.
• [44]Hoen PW, Conradi HJ, Denollet J, Martens EJ, de Jonge P: Interview-based ratings of somatic and cognitive symptoms of depression and their impact on cardiovascular prognosis. Psychother Psychosom 2010, 79:319-320.
• [45]Linke SE, Rutledge T, Johnson BD, Vaccarino V, Bittner V, Cornell CE, Eteiba W, Sheps DS, Krantz DS, Parashar S, Bairey Merz CN: Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry 2009, 66:499-507.
• [46]Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J: Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2010, 40:807-814.
• [47]Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS: The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes 2009, 2:328-337.
• [48]Roest AM, Carney RM, Freedland KE, Martens EJ, Denollet J, De Jonge P: Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study. J Affect Disord 2013.
• [49]Barefoot JC, Brummett BH, Helms MJ, Mark DB, Siegler IC, Williams RB: Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000, 62:790-795.
• [50]Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C: Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010, 72:874-881.
• [51]de Jonge P, Ormel J, van den Brink RH, van Melle JP, Spijkerman TA, Kuijper A, van Veldhuisen DJ, van den Berg MP, Honig A, Crijns HJ, Schene AH: Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006, 163:138-144.
• [52]Roest AM, Thombs BD, Grace SL, Stewart DE, Abbey SE, de Jonge P: Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality. J Affect Disord 2011, 131:158-163.
• [53]Irvine J, Basinski A, Baker B, Jandciu S, Paquette M, Cairns J, Connolly S, Roberts R, Gent M, Dorian P: Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999, 61:729-737.
• [54]Pedersen SS, Denollet J, Daemen J, van de Sande M, de Jaegere PT, Serruys PW, Erdman RA, van Domburg RT: Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007, 62:455-461.
• [55]Tully PJ, Winefield HR, Baker RA, Turnbull DA, de Jonge P: Confirmatory factor analysis of the Beck Depression Inventory-II and the association with cardiac morbidity and mortality after coronary revascularization. J Health Psychol 2011, 16:584-595.
• [56]Carney RM, Freedland KE: Is there a high-risk subtype of depression in patients with coronary heart disease? Curr Psychiatry Rep 2012, 14:1-7.
• [57]Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS: National Comorbidity Survey Replication: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
• [58]Hasin DS, Goodwin RD, Stinson FS, Grant BF: Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005, 62:1097-1106.
• [59]Rice JP, Rochberg N, Endicott J, Lavori PW, Miller C: Stability of psychiatric diagnoses, an application to the affective disorders. Arch Gen Psychiatry 1992, 49:824-830.
• [60]Ben-Zeev D, Young MA: Accuracy of hospitalized depressed patients' and healthy controls' retrospective symptom reports: an experience sampling study. J Nerv Ment Dis 2010, 198:280-285.
• [61]Carney RM, Freedland KE: Depression in patients with coronary heart disease. Am J Med 2008, 121:S20-S27.
• [62]Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH: Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006. Diabetes Res Clin Pract 2009, 83:268-279.
• [63]Zuidersma M, Thombs BD, de Jonge P: Onset and recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: a systematic review. Psychother Psychosom 2011, 80:227-237.
• [64]Valkanova V, Ebmeier KP: Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry 2013, 73:406-413.
• [65]Alexopoulos GS: The vascular depression hypothesis: 10 years later. Biol Psychiatry 2006, 60:1304-1305.
• [66]Zuidersma M, Ormel J, Conradi HJ, de Jonge P: An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction. Psychol Med 2012, 42:683-693.
• [67]Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD, Schiller NB, Browner WS: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
• [68]Freedland KE, Carney RM, Skala JA: Depression and smoking in coronary heart disease. Psychosom Med 2005, 67:S42-S46.
• [69]Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS: Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995, 14:88-90.
• [70]Gehi A, Haas D, Pipkin S, Whooley MA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005, 165:2508-2513.
• [71]Rieckmann N, Burg MM, Kronish IM, Chaplin WF, Schwartz JE, Davidson KW: Aspirin adherence, depression and one-year prognosis after acute coronary syndrome. Psychother Psychosom 2011, 80:316-318.
• [72]Leifheit-Limson EC, Kasl SV, Lin H, Buchanan DM, Peterson PN, Spertus JA, Lichtman JH: Adherence to risk factor management instructions after acute myocardial infarction: the role of emotional support and depressive symptoms. Ann Behav Med 2012, 43:198-207.
• [73]Carney RM, Steinmeyer B, Freedland KE, Blumenthal JA, Stein PK, Steinhoff WA, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Domitrovich PP, Burg MM, Hayano J, Jaffe AS: Nighttime heart rate and survival in depressed patients post acute myocardial infarction. Psychosom Med 2008, 70:757-763.
• [74]Carney RM, Freedland KE, Stein PK, Miller GE, Steinmeyer B, Rich MW, Duntley SP: Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res 2007, 62:463-467.
• [75]Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Domitrovich PP, Jaffe AS: Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005, 165:1486-1491.
• [76]Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002, 90:1279-1283.
• [77]Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P, PRIME Study Group: Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005, 111:2299-2305.
• [78]Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S: Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 2007, 62:314-320.
• [79]Vaccarino V, Johnson BD, Sheps DS, Reis SE, Kelsey SF, Bittner V, Rutledge T, Shaw LJ, Sopko G, Bairey Merz CN: National Heart, Lung, and Blood Institute: Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 2007, 50:2044-2050.
• [80]Frasure-Smith N, Lesperance F, Irwin MR, Talajic M, Pollock BG: The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun 2009, 23:1140-1147.
• [81]Bjerkeset O, Romild U, Smith GD, Hveem K: The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study. Psychol Med 2011, 41:345-352.
• [82]Duivis HE, De JP, Penninx BW, Na BY, Cohen BE, Whooley MA: Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 2011, 168:913-920.
• [83]Poole L, Dickens C, Steptoe A: The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res 2011, 71:61-68.
• [84]Kendler KS, Gardner CO, Fiske A, Gatz M: Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry 2009, 66:857-863.
• [85]Carney RM, Freedland KE: Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003, 54:241-247.
• [86]Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA: Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003, 290:215-221.
• [87]Kurdyak PA, Chong A, Gnam WH, Goering P, Alter DA: Depression and self-reported functional status: impact on mortality following acute myocardial infarction. J Eval Clin Pract 2011, 17:444-451.
• [88]Dodson JA, Arnold SV, Reid KJ, Gill TM, Rich MW, Masoudi FA, Spertus JA, Krumholz HM, Alexander KP: Physical function and independence 1 year after myocardial infarction: observations from the Translational Research Investigating Underlying disparities in recovery from acute Myocardial infarction: Patients' Health status registry. Am Heart J 2012, 163:790-796.
• [89]Steffens DC, O'Connor CM, Jiang WJ, Pieper CF, Kuchibhatla MN, Arias RM, Look A, Davenport C, Gonzalez MB, Krishnan KR: The effect of major depression on functional status in patients with coronary artery disease. J Am Geriatr Soc 1999, 47:319-322.
• [90]Guico-Pabia CJ, Fayyad RS, Soares CN: Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis. Int Clin Psychopharmacol 2012, 27:1-7.
• [91]Katon WJ: Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011, 13:7-23.
• [92]McCaffery JM, Frasure-Smith N, Dubé MP, Théroux P, Rouleau GA, Duan Q, Lespérance F: Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006, 68:187-200.
• [93]Scherrer JF, Xian H, Bucholz KK, Eisen SA, Lyons MJ, Goldberg J, Tsuang M, True WR: A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 2003, 65:548-557.
• [94]Xian H, Scherrer JF, Franz CE, McCaffery J, Stein PK, Lyons MJ, Jacobsen K, Eisen SA, Kremen WS: Genetic vulnerability and phenotypic expression of depression and risk for ischemic heart disease in the Vietnam era twin study of aging. Psychosom Med 2010, 72:370-375.
• [95]Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M: Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
• [96]Jiang W, Davidson JR: Antidepressant therapy in patients with ischemic heart disease. Am Heart J 2005, 150:871-881.
• [97]Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC: CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-379.
• [98]Vieweg WV, Julius DA, Fernandez A, Wulsin LR, Mohanty PK, Beatty-Brooks M, Hasnain M, Pandurangi AK: Treatment of depression in patients with coronary heart disease. Am J Med 2006, 119:567-573.
• [99]Taylor D, Meader N, Bird V, Pilling S, Creed F, Goldberg D: Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry 2011, 198:179-188.
• [100]Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N: Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD): Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106-3116.
• [101]Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM: Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010, 170:600-608.
• [102]Mathew SJ: Treatment-resistant depression: recent developments and future directions. Depress Anxiety 2008, 25:989-992.
• [103]Huijbregts KM, van der Feltz-Cornelis CM, van Marwijk HW, de Jong FJ, van der Windt DA, Beekman AT: Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review. J Psychosom Res 2010, 68:511-519.
• [104]Preskorn SH: Treatment options for the patient who does not respond well to initial antidepressant therapy. J Psychiatr Pract 2009, 15:202-210.
• [105]Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ: What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 2009, 60:1439-1445.
• [106]Sinyor M, Schaffer A, Levitt A: The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry 2010, 55:126-135.
• [107]Trivedi RB, Nieuwsma JA, Williams JW Jr: Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review. J Gen Intern Med 2011, 26:643-650.